SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-017708
Filing Date
2020-06-25
Accepted
2020-06-25 20:02:36
Documents
2
Period of Report
2020-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2943
2 EX-24 DOCUMENT attachment1.htm EX-24 4711
  Complete submission text file 0000899243-20-017708.txt   9035
Mailing Address C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY A0 V5G 4W8
Business Address
GANNON STEVEN (Reporting) CIK: 0001643085 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39344 | Film No.: 20990643

Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Issuer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)